Role of Levofloxacin in the Treatment of Rhinosinusitis | Infection Update

Role of Levofloxacin in the Treatment of Rhinosinusitis

21 June, 2018

Role of Levofloxacin in the Treatment of Rhinosinusitis

Michael D. Poole, MD, PhD

Question

Q 1.		Acute and chronic rhinosinusitis: definition
Q 2.		Important patient factors for prescribing
Q 3.		Chronic rhinosinusitis: clarifying the definition
Q 4.		Bacterial etiology: acute and chronic rhinosinusitis
Q 5.		Different geographical regions and bacterial etiology
Q 6.		Drug-resistant pathogens in upper respiratory tract infections
Q 7.		Newer macrolides: inappropriate for first-line therapy of respiratory tract infections?
Q 8.		In vitro activity of levofloxacin
Q 9.		Pharmacokinetic/pharmacodynamic features of levofloxacin
Q10.		Recent recognized treatment guidelines
Q11.		Clinical trials using fluoroquinolones
Q12.		Optimal treatment duration and dosage
Q13.		Relative safety profile of levofloxacin
Q14.		Cost-effectiveness of different antimicrobials

LATEST TOPICS